We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

10 hedge funds and large institutions have $231K invested in Tenax Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.26% more ownership

Funds ownership: 0.01% → 0.27% (+0.26%)

29% less funds holding

Funds holding: 14 → 10 (-4)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

67% less capital invested

Capital invested by funds: $692K → $231K (-$461K)

Holders
10
Holders Change
-4
Holders Change %
-28.57%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Corient Private Wealth
Corient Private Wealth
Florida
+$250K
2
State Street
State Street
Massachusetts
+$115K
3
VF
Virtu Financial
New York
+$110K
4
Verition Fund Management
Verition Fund Management
Connecticut
+$56.8K
5
TSS
Two Sigma Securities
New York
+$51.6K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$133K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$19.4K
3
UBS Group
UBS Group
Switzerland
-$17.7K
4
Renaissance Technologies
Renaissance Technologies
New York
-$7K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Corient Private Wealth
1
Corient Private Wealth
Florida
$89K +$250K +2,393 New
State Street
2
State Street
Massachusetts
$44.2K +$115K +1,102 +1,267%
VF
3
Virtu Financial
New York
$39K +$110K +1,055 New
Verition Fund Management
4
Verition Fund Management
Connecticut
$20.3K +$56.8K +545 New
TSS
5
Two Sigma Securities
New York
$20K +$51.6K +495 +1,179%
BlackRock
6
BlackRock
New York
$11.1K – – –
APP
7
Avantax Planning Partners
Iowa
$4.65K +$13K +125 New
TRCT
8
Tower Research Capital (TRC)
New York
$2K +$6.26K +60 +1,000%
Morgan Stanley
9
Morgan Stanley
New York
$316 – – –
Wells Fargo
10
Wells Fargo
California
$30 +$104 +1 New
AF
11
Allworth Financial
California
$1 – – –
TAM
12
Tucker Asset Management
Colorado
$1 – – –
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
– -$133K -756 Closed
Vanguard Group
14
Vanguard Group
Pennsylvania
– -$19.4K -109 Closed
UBS Group
15
UBS Group
Switzerland
– -$17.7K -101 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$7K -40 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$6K -32 Closed
Northern Trust
18
Northern Trust
Illinois
– -$3.86K -22 Closed
HF
19
HRT Financial
New York
– -$2K -16 Closed
PNC Financial Services Group
20
PNC Financial Services Group
Pennsylvania
– -$22 – –

TENX Hedge Fund Activity: Q1 2023 in Review

10 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2023, worth a combined $231K — down 67% from $692K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TENX and 5 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Corient Private Wealth, opening a new position worth an estimated $250K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $133K sold.

  • 10 institutional investors held Tenax Therapeutics (TENX) as of Q1 2023, down from 14 in Q4 2022.
  • Funds reported $231K of Tenax Therapeutics stock for Q1 2023, down 67% quarter-over-quarter.
  • 5 funds opened new Tenax Therapeutics positions in Q1 2023 and 8 closed out, a net change of -3 holders.
  • The largest Tenax Therapeutics buyer in Q1 2023 was Corient Private Wealth, an estimated $250K added.
  • The largest Tenax Therapeutics seller in Q1 2023 was Acadian Asset Management, an estimated $133K sold.

Based on aggregated 13F filings for Q1 2023.